Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Collene R. Jeter Image

      Collene R. Jeter, Ph.D.

      Department of Epigenetics and Molecular Carcinogenesis, Division of Discovery Science

      About Dr. Jeter

      Dr. Jeter has ~15 years of experience performing detailed cell and molecular analyses of normal and tumor tissues contributing to our understanding of molecular oncogenesis. Her lab dissected the mechanisms underlying NANOG-mediated oncogenesis and prostate cancer progression to castration resistance. Other ongoing collaborative research includes studies of DNA damage repair, protein subcellular localization and dynamics, cancer cell metastasis and cell-fate specification. Her independent research aiming to ascertain how attributes of stem cells fuel tumorigenesis largely centered on confocal microscopy. Advanced confocal includes volumetric high-resolution multispectral imaging, protein-protein interaction assays, super-resolution imaging, biological phenotyping and time-lapse imaging. The recent addition of a Leica TCS SP8 DIVE multiphoton microscope has permitted the development of 3D volumetric and intravital imaging. Dr. Jeter currently manages the EMC departmental LSM880 laser scanning confocal and multiphoton microscopes and as Co-Director of the Flow Cytometry and Cell Imaging Core, trains all departmental users and continues to develop advanced confocal, multiphoton and supportive wet lab capabilities at her facility. User training, protocol development and collaborative confocal imaging requests are welcome.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Research Associate Professor, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Research Associate Professor, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Research Interests

      Dr. Jeter's research aims to illuminate tumor heterogeneity and the stem cell attributes of cancer cells. Potentially encompassing both the cancer cell-of-origin and oncogenic reprogramming they apply laser scanning confocal microscopy to investigate neoplastic stem-like cells in situ and NextGen Sequencing to query gene expression profiles of purified candidate CSCs ex vivo. Using these cutting-edge methods, the pluripotency factor NANOG convergence on the master transcription factors AR and FOXA1 (Jeter et al., 2016) was recently discovered to underlie NANOG-mediated prostate cancer castration-resistance phenotypes and gene signatures (Jeter et al., 2011). Fluorescence-tagged transgenic mouse models are also being applied to query tumor development and cancer origins via confocal and RNA-Seq transcriptome profiling, such as a novel prostate-specific dox-repressible H2B-GFP label-retaining cell system utilized to characterize a luminal stem/progenitor cell implicated in prostate homeostasis and prostate cancer. Currently they are working to establish methods to interrogate cancer stem cell reprogramming of the bone marrow niche, an event that may presage or augment bone metastases. Other interests include: 3D reconstructions and imaging of thicker tissue/tumor specimens, time-lapse imaging and lineage tracing, molecular mechanisms of DNA damage repair, and protein proximity and dynamics (e.g., FRET/FRAP). As director of Cell Imaging (part of our Flow Cytometry and Cell Imaging Core) at UT MD Anderson Cancer Center, collaborative investigations in any of these imaging areas are welcome.

      Education & Training

      Degree-Granting Education

      2004The University of Texas, Austin, Texas, US, Molecular and Cellular Biology, Ph.D
      1993The University of Texas, Austin, Texas, US, Molecular Biology, BS

      Postgraduate Training

      2004-2009Research Fellowship, Molecular mechanisms of tumorigenesis and cancer cell biology, The University of Texas MD Anderson Cancer Center, Smithville, Texas

      Experience & Service

      Faculty Academic Appointments

      Research Assistant Professor, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2016 - 2024

      Instructor, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2009 - 2016

      Postdoctoral Fellow, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2004 - 2009

      Ph.D. Candidate, Cellular and Molecular Biology, The University of Texas, Austin, TX, 2001 - 2004

      Graduate Research Assistant, Cellular and Molecular Biology, The University of Texas, Austin, TX, 1998 - 2004

      Administrative Appointments/Responsibilities

      Interim Director, Advanced Microscopy Core, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Co-Director, Flow Cytometry and Cell Imaging Core, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present

      Other Professional Positions

      Research Assistant, The University of Texas, Austin, TX, 1998 - 1998

      Sr. Research Assistant, The University of Texas Health Science Center, San Antonio, TX, 1996 - 1998

      Sr. Lab Tech/Assistant Scientist, The University of Minnesota Mayo Clinic, Minneapolis, MN, 1994 - 1996

      Extramural Institutional Committee Activities

      Executive Oversight Committee Board Member, Recombinant Antibody Protein Core (RAPC), The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, South Campus Research Building 5 (SCR5) Planning Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Shared Resource Committee (SHREC), The University of Texas MD Anderson Cancer Center, 2021 - 2022

      Member, Shared Resource and Service Center Oversight Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Chair, Postdoctoral Association, Mentor Award Subcommittee, The University of Texas MD Anderson Cancer Center, 2007

      Chair, Postdoctoral Association, Science Park Subcommittee, The University of Texas MD Anderson Cancer Center, 2005 - 2006

      Member, Postdoctoral Association, Steering Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2009

      Honors & Awards

      2017MBL Fellowship - Optical Microscopy & Imaging Course, Marine Biological Laboratories
      2009Outstanding Graduate Scholar, American Urological Association Research Foundation
      2007 - 2009Research Scholar, American Urological Association Research Foundation
      2004 - 2006Ruth L. Kirschstein National Research Service Award, University of Texas M.D. Anderson Cancer Center
      2003Bruton Fellow, University of Texas at Austin

      Professional Memberships

      Texas Microcospy Society

      2025 - Present

      Bioimaging North America

      2024 - Present

      American Society for Cell Biology

      2022 - Present

      Association of Biomolecular Research Facilities

      2018 - Present

      American Association for Cancer Research

      2007 - Present

      International Society for Stem Cell Research

      2005 - 2009

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Hosted: TauSTED Xtend Gentle super-resolution microscopy. Invited. Hosted: TauSTED Xtend Gentle super-resolution microscopy. Houston, Texas, US.
      2. 2025. Hosted: Breaking through resolution barriers;Introducing the ONI Nanoimager super-resolution microscope. Invited. Hosted: Breaking through resolution barriers;Introducing the ONI Nanoimager super-resolution microscope. Houston, Texas, US.
      3. 2024. Hosted: Cell DIVE Multiplexed Imaging with Aivia AI-driven image analysis software. Invited. Hosted: Cell DIVE Multiplexed Imaging with Aivia AI-driven image analysis software. Houston, Texas, US.
      4. 2024. Hosted: Automated High Content Imaging and Analysis with ImageXpress Confocal HTai. Invited. Hosted: Automated High Content Imaging and Analysis with ImageXpress Confocal HTai. Houston, Texas, US.
      5. 2024. Flourescence Microscopy Services at MDACC South Campus. Invited. University of Texas MDA Cancer Center Townhall. Houston, Texas, US.
      6. 2024. Hosted: IMARIS Workshop 3D/4D Visualization & Analysis. Invited. Hosted: IMARIS Workshop 3D/4D Visualization & Analysis. Houston, Texas, US.
      7. 2023. Hosted: Super-Resolution Microscopy Demo and Workshop for the Nikon AX R NSPARC with iLas Ring TIRF and SMLM. Conference. Hosted: Super-Resolution Microscopy Demo and Workshop for the Nikon AX R NSPARC with iLas Ring TIRF and SMLM. Houston, TX, US.
      8. 2023. Hosted: Andor DragonFly Spinning Disk Confocal Seminar and Demo. Conference. Hosted: Andor DragonFly Spinning Disk Confocal Seminar and Demo. Houston, TX, US.
      9. 2023. Hosted: Introducing Nikon AX/AX R with NSPARC. Invited. Hosted: Introducing Nikon AX/AX R with NSPARC. Houston, Texas, US.
      10. 2023. Hosted: Zeiss Lightsheet Seminar and Demo/Workshop. Conference. Hosted: Zeiss Lightsheet Seminar and Demo/Workshop. Houston, TX, US.
      11. 2023. Hosted: ZEISS Lattice Lightsheet 7 Discovering the subcellular dynamics of life with ZEISS Lattice Lightsheet 7. Invited. Hosted: ZEISS Lattice Lightsheet 7 Discovering the subcellular dynamics of life with ZEISS Lattice Lightsheet 7. Houston, Texas, US.
      12. 2023. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Conference. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Houston, TX, US.
      13. 2023. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Conference. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Houston, TX, US.
      14. 2023. The Advanced Microscopy Core and EMC Cell Imaging: High Resolution Optical Microscopy. Conference. The Advanced Microscopy Core and EMC Cell Imaging: High Resolution Optical Microscopy. Houston, TX, US.

      Regional Presentations

      1. 2023. Work-in-Progress. Conference. Work-in-Progress, US.
      2. 2021. Work-in-Progress. Conference. Work-in-Progress, US.
      3. 2019. Work-in-Progress. Conference. Work-in-Progress, US.
      4. 2018. Work-in-Progress. Conference. Work-in-Progress, US.
      5. 2017. Work-in-Progress. Conference. Work-in-Progress, US.
      6. 2016. Epigenetics. Conference. Epigenetics, US.
      7. 2016. Work-in-Progress. Conference. Work-in-Progress, US.
      8. 2015. Work-in-Progress. Conference. Work-in-Progress, US.
      9. 2013. Molecular Oncogenesis. Conference. Molecular Oncogenesis, US.
      10. 2012. Genetics. Conference. Genetics, US.

      National Presentations

      1. 2020. Tissue preparation and immunofluorescence staining for multispectral volumetric multiphoton and confocal microscopy. Conference. Tissue preparation and immunofluorescence staining for multispectral volumetric multiphoton and confocal microscopy. Palm Springs, CA, US.
      2. 2014. NANOG regulation of prostate tumorigenesis. Conference. NANOG regulation of prostate tumorigenesis. Keystone, CO, US.
      3. 2012. Molecular oncogenesis of NANOG in castration-resistant prostate cancer. Conference. Molecular oncogenesis of NANOG in castration-resistant prostate cancer, US.
      4. 2009. A novel strategy to isolate live label-retaining cells from prostate tumors. Conference. Research Scholar's Program, US.
      5. 2008. Essential role of the self-renewal gene Nanog in regulating tumor development. Conference. Essential role of the self-renewal gene Nanog in regulating tumor development, US.

      International Presentations

      1. 2025. Advanced Microscopy Core Facility - UT MD Anderson Cancer Center. Poster. Texas Society of Microscopy Annual Meeting. Houston, US.
      2. 2023. High Throughput Mutant Library Screening via Confocal Microscopy Spatial Analysis. Conference. High Throughput Mutant Library Screening via Confocal Microscopy Spatial Analysis. Porto, PT.
      3. 2023. Usp22 loss of function leads to Purkinje cells degeneration and glial deregulation in the cerebellum of adult mice. Conference. Usp22 loss of function leads to Purkinje cells degeneration and glial deregulation in the cerebellum of adult mice. British Columbia, CA.
      4. 2010. Nanog: Origins and implications in cancer cells. Conference. Nanog: Origins and implications in cancer cells, US.
      5. 2005. Cancer stem-like cells in human cancer cell cultures and xenograft tumors: Expression and roles of 'stemness' genes. Conference. Cancer stem-like cells in human cancer cell cultures and xenograft tumors: Expression and roles of 'stemness' genes, US.

      Formal Peers

      1. 2013. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. Invited, TX, US.
      2. 2013. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. Invited. San Antonio, TX, US.
      3. 2012. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. Invited. College Station, TX, US.
      4. 2009. The Molecular Basis of the Resemblance of Cancer Cells and Stem Cells. Invited. Temple, TX, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2027 - 2028
      Title:Leica Stellaris Tau-STED Multimodal Microscope
      Funding Source:NIH
      Role:PI
      ID:OD042799
      Date: 2025 - 2026
      Title:Custom Nikon NSPARC/iLas RingTIRF/SMLM Super-resolution Microscope
      Funding Source:NIH
      Role:PI
      ID:S10OD038152
      Date: 2024 - 2028
      Title:Noncanonical roles of Bim in heat shock-induced cell death
      Funding Source:NIH
      Role:Co-PI
      ID:R01GM155335-01
      Date: 2024 - 2029
      Title:Defeating Cancer with Immunomodulatory Bacterial Therapeutics
      Funding Source:NIH/NCI
      Role:Co-I
      ID:FP00020827
      Date: 2024 - 2029
      Title:Interrogating and Targeting the Neuro-immune Axis in Recurrent GBM
      Funding Source:NIH/NINDS
      Role:Collaborator
      ID:R01 NS136160-01
      Date: 2023 - 2028
      Title:Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
      Funding Source:NIH/NINDS
      Role:Co-I
      ID:R01 NS127922-01A1
      Date: 2021 - 2022
      Title:Illuminating pathogenesis via Elyra 7 Lattice SIM Super-resolution Microscopy
      Funding Source:NIH
      Role:PI
      ID:S10 OD030241
      Date: 2018 - 2020
      Title:Cancer stem cell-induced remodeling of the bone marrow niche
      Funding Source:Emerson Collective Cancer Research Fund
      Role:PI
      Date: 2018 - 2023
      Title:Defining USP22 Functions During Mammalian Development
      Funding Source:NIH/NICHD
      Role:Co-I
      ID:R01 HD094400-05A1
      Date: 2017 - 2019
      Title:Cancer stem cell-induced remodeling of the bone marrow niche
      Funding Source:Institutional/IRG
      Role:PI
      ID:IRG
      Date: 2017 - 2023
      Title:The University of Texas MD Anderson Cancer Center Science Park Flow Cytometry and Cell Imaging Core
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP170628
      Date: 2016 - 2018
      Title:Cancer stem cell-induced remodeling of the tumor microenvironment
      Funding Source:Institutional/IRG
      Role:PI
      ID:IRG
      Date: 2012 - 2015
      Title:Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:RP120394
      Date: 2011 - 2014
      Title:Characterization of Slow-Cycling Prostate Cancer Cells as Potential Therapeutic Targets
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:PI
      ID:W81XWH-10-PCRP-IDA (PC101049)
      Date: 2011 - 2012
      Title:A Novel Transgenic Mouse Model to Study the Impact of Environmental Xenoestrogens on Slow-Cycling Prostate Stem Cell Susceptibility to Transformation
      Funding Source:NIEHS/CRED
      Role:PI
      ID:CRED
      Date: 2007 - 2009
      Title:A Novel Strategy to Isolate Live Label-Retaining Cells from Prostate Tumors
      Funding Source:The American Urological Association Research Foundation
      Role:PI
      Title:The BRCA1-WWOX interaction in breast cancer development and treatment resistance
      Funding Source:Department of Defense (DOD)
      Role:Co-I
      ID:1252745

      Selected Publications

      Peer-Reviewed Articles

      1. Shi, L, Dasovich, M, Horton, JR, Liu, H, Zhan, Q, Manickavinayaham, S, Jeter, CR, Mixon, IJ, Zehrbach, NM, Ishak, CA, Yoon, JH, Cheng, X, Leung, AK, Bedford, MT. Nuclear poly(A)-binding protein and nucleolin utilize their RNA recognition motifs to read PAR chains. Nucleic acids research 53(20), 2025. e-Pub 2025. PMID: 41182901.
      2. Bowen, MB, Melendez, B, Zhang, Q, Moreno, D, Peralta, L, Chan, W, Jeter, CR, Tan, L, Zal, MA, Lorenzi, PL, Dunner, K, Yang, RK, Broaddus, R, Celestino, J, Gokul, N, Whitley, EM, Scoville, DM, Kim, TH, Jeong, JW, Schmandt, R, Lu, KH, Kim, HE, Yates, MS. Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome–associated MSH2-deficient endometrial cancer. JCI Insight 10(6), 2025. e-Pub 2025. PMID: 39964762.
      3. Awasthi, S, Dobrolecki, LE, Sallas, C, Zhang, X, Li, Y, Khazaei, S, Ghosh, S, Jeter, CR, Liu, J, Mills, GB, Westin, SN, Lewis, MT, Peng, W, Sood, AK, Yap, TA, Yi, SS, McGrail, DJ, Sahni, N. UBA1 inhibition sensitizes cancer cells to PARP inhibitors. Cell Reports Medicine 5(12), 2024. e-Pub 2024. PMID: 39626673.
      4. Mise, K, Long, J, Galvan, D, Ye, Z, Fan, G, Sharma, R, Serysheva, I, Moore, TI, Jeter, CR, Anna Zal, M, Araki, M, Wada, J, Schumacker, PT, Chang, B, Danesh, FR. NDUFS4 regulates cristae remodeling in diabetic kidney disease. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38438382.
      5. Patel, B, Zhou, Y, Babcock, R, Ma, F, Zal, MA, Kumar, D, Medik, YB, Kahn, LS, Pineda, JE, Park, EM, Schneider, S, Tang, X, Raso, G, Jeter, CR, Zal, T, Dwyer, KC, Keyomarsi, K, Giancotti, FG, Colla, S, Watowich, SS. STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response. Leukemia 38(5):1143-1155, 2024. e-Pub 2024. PMID: 38467768.
      6. Wible, D, Parikh, Z, Cho, EJ, Chen, M, Jeter, CR, Mukhopadhyay, S, Dalby, KN, Varadarajan, S, Bratton, SB. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control. Cell Death & Dis 15(1), 2024. e-Pub 2024. PMID: 38253602.
      7. Li, Y, Dobrolecki, LE, Sallas, C, Zhang, X, Kerr, TD, Bisht, D, Wang, Y, Awasthi, S, Kaundal, B, Wu, S, Peng, W, Mendillo, ML, Lu, Y, Jeter, CR, Peng, G, Liu, J, Westin, SN, Sood, AK, Lewis, MT, Das, J, Yi, S, Bedford, MT, McGrail, DJ, Sahni, N. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. Cell Reports Medicine 4(12), 2023. e-Pub 2023. PMID: 38118413.
      8. Hussain T, Sanchez K, Crayton J, Saha D, Jeter CR, Lu Y, Abba M, Seo R, Noebels JL, Fonken L, Aldaz CM. WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12. Prog Neurobiol 223(IF- 11.7):102425, 2023. e-Pub 2023. PMID: 36828035.
      9. Yang F, Chen J, Liu B, Gao G, Sebastian M, Jeter CR, Shen J, Person MD, Bedford MT. SPINDOC binds PARP1 to facilitate PARylation. Nat Commun 12(1):6362, 2021. e-Pub 2021. PMID: 34737271.
      10. Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter CR, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun 10(1):5494, 2019. e-Pub 2019. PMID: 31792211.
      11. Koutelou E, Wang L, Schibler AC, Chao HP, Kuang X, Lin K, Lu Y, Shen J, Jeter CR, Salinger A, Wilson M, Chen YC, Atanassov BS, Tang DG, Dent SYR. USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta. Development 146(4), 2019. e-Pub 2019. PMID: 30718289.
      12. Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter CR, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, Beltran H, Shen J, Chatta G, Puzanov I, Mohler JL, Wang J, Zhao R, Kirk J, Chen X, Tang DG. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9(1):3600, 2018. e-Pub 2018. PMID: 30190514.
      13. Wang L, Koutelou E, Hirsch C, McCarthy R, Schibler A, Lin K, Lu Y, Jeter CR, Shen J, Barton MC, Dent SYR. GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes during Early Embryoid Body Differentiation. Stem Cell Reports 10(1):287-299, 2018. e-Pub 2018.
      14. Zhang D, Jeter CR, Gong S, Tracz A, Lu Y, Shen J, Tang DG. Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration. Stem Cell Reports 10(1):228-242, 2018. e-Pub 2018. PMID: 29276153.
      15. Liu B, Gong S, Li Q, Chen X, Moore J, Suraneni MV, Badeaux MD, Jeter, CR, Shen J, Mehmood R, Fan Q, Tang DG. Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model. Oncotarget 8(32):52746-60, 2017. e-Pub 2017.
      16. Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, Tang DG. NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Disc 2:16041, 2016. e-Pub 2016.
      17. Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter CR, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG. Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer. Clin Cancer Res 22(17):4505-16, 2016. e-Pub 2016.
      18. Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter CR, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. Oncotarget, 2016. e-Pub 2016. PMID: 27447749.
      19. Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter CR, Liu C, Honorio S, Li H, Davis T, Suraneni M, Laffin B, Qin J, Li Q, Yang T, Whitney P, Shen J, Huang J, Tang DG. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget 6(27):23959-86, 2015. e-Pub 2015.
      20. Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter CR, Chen X, Vlassov AV, Tang DG. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 74(15):4183-95, 2014. e-Pub 2014. PMID: 24903149.
      21. Liu B, Badeaux MD, Choy G, Chandra D, Shen I, Jeter CR, Rycaj K, Lee CF, Person MD, Liu C, Chen Y, Shen J, Jung SY, Qin J, Tang DG. Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species. PLoS One 9(3):e90615, 2014. e-Pub 2014. PMID: 24598770.
      22. Ferguson BW, Gao X, Zelazowski MJ, Lee J, Jeter CR, Abba MC, Aldaz CM. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding. BMC Cancer 13:593, 2013. e-Pub 2013.
      23. Badeaux MA, Jeter CR, Gong S, Liu B, Suraneni MV, Rundhaug J, Fischer SM, Yang T, Kusewitt D, Tang DG. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle 12(15):2395-408, 2013. e-Pub 2013. PMID: 23839044.
      24. Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10(5):556-69, 2012. e-Pub 2012. PMID: 22560078.
      25. Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ, Tang DG. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30(36):3833-3845, 2011. e-Pub 2011.
      26. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter CR, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17(2):211-5, 2011. e-Pub 2011.
      27. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27(5):993-1005, 2009. e-Pub 2009. PMID: 19415763.
      28. Chen X, Schneider-Broussard R, Hollowell D, McArthur M, Jeter CR, Benavides F, DiGiovanni J, Tang DG. Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. Differentiation 77(3):324-34, 2009. e-Pub 2009. PMID: 19272531.
      29. Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG. Methodologies in assaying prostate cancer stem cells. Methods Mol Biol 568:85-138, 2009. e-Pub 2009. PMID: 19582423.
      30. Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, Tang DG. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem 283(41):27957-72, 2008. e-Pub 2008. PMID: 18662989.
      31. Jeter CR, Roux SJ. Plant responses to extracellular nucleotides: Cellular processes and biological effects. Purinergic Signal 2(3):443-9, 2006. e-Pub 2006. PMID: 18404482.
      32. Jeter CR, Tang W, Henaff E, Butterfield T, Roux SJ. Evidence of a novel cell signaling role for extracellular adenosine triphosphates and diphosphates in Arabidopsis. Plant Cell 16(10):2652-64, 2004. e-Pub 2004. PMID: 15367717.
      33. Steinebrunner I, Jeter CR, Song C, Roux SJ. Molecular and biochemical Comparison of two different apyrases from Arabidopsis thaliana. Plant Physiology and Biochemistry 38:913-922, 2000. e-Pub 2000.

      Invited Articles

      1. Gong S, Li Q, Jeter CR, Fan Q, Tang DG, Liu B. Regulation of NANOG in cancer cells. Mol Carcinog 54(9):679-87, 2015. e-Pub 2015. PMID: 26013997.
      2. Jeter CR, Yang T, Wang J, Chao HP, Tang DG. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells 33(8):2381-90, 2015. e-Pub 2015. PMID: 25821200.
      3. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter CR. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46(1):1-14, 2007. e-Pub 2007. PMID: 16921491.

      Review Articles

      1. Basu S, Dong Y, Kumar R, Jeter CR, Tang DG. Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Semin Cancer Biol S1044-579X(21):90-103, 2022. e-Pub 2022. PMID: 33979674.

      Professional Educational Materials

      1. . OMX Structured Illumination Microscopy (SIM), 2023.
      2. . Zeiss Lightsheet 7, 2023.
      3. . FRET/FRAP, 2019.
      4. . Vibratome Sectioning Protocol, 2018.
      5. . Leica TCS SP8 Multiphoton Microscope Standard Operating Procedure, 2018.
      6. . LSM880 Unmixing Spectral Crosstalk Standard Operating Procedure, 2017.
      7. . Laser Microirradiation Standard Operating Procedure, 2017.
      8. . LSM880 AiryScan Super-resolution Imaging Standard Operating Procedure, 2017.
      9. . Immunofluorescence Staining Protocol, 2017.
      10. . Zeiss LSM880 Confocal Standard Operating Procedure, 2016.

      Other Articles

      1. Mise, K, Long, J, Galvan, D, Ye, Z, Fan, G, Sharma, R, Serysheva, I, Moore, T, Jeter, CR, Anna Zal, M, Araki, M, Wada, J, Schumacker, PT, Chang, B, Danesh, FR Publisher correction. Nature communications 15(1), 2024. PMID: 38589378.
      2. Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter CR, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun 11(1):2895, 2020. PMID: 32499578.

      Book Chapters

      1. Jeter, CR. Investigating the Role of the Embryonic Stem Cell Self-Renewal Gene NANOG in Neoplastic Processes. In: Stem Cells and Cancer Stem Cells. Springer, 2013.
      2. Jeter, CR, Tang, DG. Prostate Tissue Stem Cells and Prostate Cancer Progression. In: Encyclopedia of Molecular Cell Biology and Molecular Medicine. Wiley-VCH, 2012.
      3. Jeter CR, Tang DG. Prostate cancer stem cells. In: Cancer Stem Cells. Cambridge University Press, 2009.
      4. Roux S, Song C, Jeter CR. Regulation of plant growth and development by extracellular nucleotides. In: Communication in Plants. Springer, 221-234, 2006.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top